📣 VC round data is live. Check it out!
- Public Comps
- Synektik
Synektik Valuation Multiples
Discover revenue and EBITDA valuation multiples for Synektik and similar public comparables like CeriBell, SD Biosensor, SI-BONE, Sunmax Biotechnology and more.
Synektik Overview
About Synektik
Synektik SA is a supplier of innovative products, services and IT solutions for diagnostic imaging and nuclear medicine. It sells medical devices and IT solutions used in radiology and operates research laboratory for diagnostic imaging systems and a service centre for medical equipment. Its operating segments include the sale of medical equipment used in radiology and nuclear medicine and IT solutions, Maintenance services for medical equipment as well as acceptance and specialist tests and Radiopharmaceutical production.
Founded
2011
HQ

Employees
N/A
Website
Financials (LTM)
EV
$613M
Valuation Multiples
Start free trialSynektik Financials
Synektik reported last 12-month revenue of $240M and EBITDA of $60M.
In the same LTM period, Synektik generated $104M in gross profit, $60M in EBITDA, and $41M in net income.
Revenue (LTM)
Synektik P&L
In the most recent fiscal year, Synektik reported revenue of $215M and EBITDA of $53M.
Synektik is profitable as of last fiscal year, with gross margin of 31%, EBITDA margin of 25%, and net margin of 17%.
Financial data powered by Morningstar, Inc.
Synektik Stock Performance
Synektik has current market cap of $650M, and enterprise value of $613M.
Market Cap Evolution
Synektik's stock price is $76.23.
Synektik share price decreased by 3.3% in the last 30 days, and increased by 29.6% in the last year.
Synektik has an EPS (earnings per share) of $4.39.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $613M | $650M | -1.9% | -3.3% | -8.9% | 29.6% | $4.39 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSynektik Valuation Multiples
Synektik trades at 2.6x EV/Revenue multiple, and 10.1x EV/EBITDA.
EV / Revenue (LTM)
Synektik Financial Valuation Multiples
As of May 20, 2026, Synektik has market cap of $650M and EV of $613M.
Synektik has a P/E ratio of 15.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Synektik Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Synektik Margins & Growth Rates
Synektik grew revenue by 18% and EBITDA by 21% in the last fiscal year.
In the most recent fiscal year, Synektik reported gross margin of 31%, EBITDA margin of 25%, and net margin of 17%.
Synektik Margins
Synektik Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Synektik Operational KPIs
Synektik's Rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Synektik's Rule of X is 33% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Synektik Competitors
Synektik competitors include CeriBell, SD Biosensor, SI-BONE, Sunmax Biotechnology, Lumibird, BrainsWay, Nanosonics, Advanced Medical Solutions Group, Bioventus and Japan Lifeline.
Most Synektik public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 5.9x | 5.3x | (10.5x) | (9.8x) | |||
| 1.1x | — | (1.2x) | — | |||
| 2.8x | 2.6x | 62.4x | 55.2x | |||
| 9.9x | — | 17.9x | — | |||
| 2.6x | 2.6x | 13.5x | 12.7x | |||
| 10.5x | 9.5x | 55.9x | 59.6x | |||
| 4.2x | 4.1x | 26.5x | 36.0x | |||
| 2.6x | 2.6x | 12.1x | 11.6x | |||
This data is available for Pro users. Sign up to see all Synektik competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Synektik
| When was Synektik founded? | Synektik was founded in 2011. |
| Where is Synektik headquartered? | Synektik is headquartered in Poland. |
| Is Synektik publicly listed? | Yes, Synektik is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Synektik? | Synektik trades under SNT ticker. |
| When did Synektik go public? | Synektik went public in 2011. |
| Who are competitors of Synektik? | Synektik main competitors include CeriBell, SD Biosensor, SI-BONE, Sunmax Biotechnology, Lumibird, BrainsWay, Nanosonics, Advanced Medical Solutions Group, Bioventus, Japan Lifeline. |
| What is the current market cap of Synektik? | Synektik's current market cap is $650M. |
| What is the current revenue of Synektik? | Synektik's last 12 months revenue is $240M. |
| What is the current revenue growth of Synektik? | Synektik revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Synektik? | Current revenue multiple of Synektik is 2.6x. |
| Is Synektik profitable? | Yes, Synektik is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Synektik? | Synektik's last 12 months EBITDA is $60M. |
| What is Synektik's EBITDA margin? | Synektik's last 12 months EBITDA margin is 25%. |
| What is the current EV/EBITDA multiple of Synektik? | Current EBITDA multiple of Synektik is 10.1x. |
| What is the current FCF of Synektik? | Synektik's last 12 months FCF is $52M. |
| What is Synektik's FCF margin? | Synektik's last 12 months FCF margin is 22%. |
| What is the current EV/FCF multiple of Synektik? | Current FCF multiple of Synektik is 11.7x. |
| How many companies Synektik has acquired to date? | Synektik hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Synektik has invested to date? | Synektik hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Synektik
Lists including Synektik
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.